• Return to Headlines

20.9% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

By David Diaz

SmarTrend identified a Downtrend for Ultragenyx Pharm (NASDAQ:RARE) on July 9th, 2019 at $56.48. In approximately 2 months, Ultragenyx Pharm has returned 20.87% as of today's recent price of $44.69.

In the past 52 weeks, Ultragenyx Pharm share prices have been bracketed by a low of $37.44 and a high of $90.98 and are now at $44.71, 19% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 1.8%.

Ultragenyx Pharmaceutical Inc. provides biotechnology services. The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Ultragenyx Pharm.

Log in and add Ultragenyx Pharm (RARE) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights ultragenyx pharm

Ticker(s): RARE